Agilon Health, Inc. $AGL Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. boosted its position in shares of Agilon Health, Inc. (NYSE:AGL) by 196.1% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 107,024 shares of the company’s stock after acquiring an additional 70,883 shares during the quarter. Russell Investments Group Ltd.’s holdings in Agilon Health were worth $463,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. SG Americas Securities LLC lifted its holdings in shares of Agilon Health by 1,271.3% in the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company’s stock valued at $624,000 after buying an additional 133,674 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Agilon Health by 21.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company’s stock valued at $432,000 after buying an additional 17,866 shares during the period. Nisa Investment Advisors LLC lifted its holdings in shares of Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after buying an additional 6,783 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Agilon Health by 41.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company’s stock valued at $644,000 after buying an additional 98,377 shares during the period. Finally, MetLife Investment Management LLC lifted its holdings in shares of Agilon Health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock valued at $332,000 after buying an additional 6,762 shares during the period.

Agilon Health Stock Up 0.4%

Shares of Agilon Health stock opened at $1.28 on Monday. Agilon Health, Inc. has a twelve month low of $0.71 and a twelve month high of $6.08. The business has a 50-day moving average price of $1.77 and a 200 day moving average price of $2.91. The firm has a market cap of $528.39 million, a PE ratio of -1.66 and a beta of 0.12.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The business had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the firm earned ($0.07) EPS. Agilon Health’s revenue for the quarter was down 5.9% on a year-over-year basis. On average, sell-side analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Robert W. Baird decreased their price objective on Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Jefferies Financial Group decreased their price objective on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a report on Friday, August 15th. Wells Fargo & Company decreased their price objective on Agilon Health from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Tuesday, May 13th. Barclays cut their price target on Agilon Health from $3.00 to $1.50 and set an “underweight” rating for the company in a research note on Wednesday, August 6th. Finally, Benchmark cut their price target on Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, August 6th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Agilon Health has a consensus rating of “Hold” and a consensus price target of $3.07.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.